DXCM - DexCom, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
San Diego,
United States
Type: Equity
DXCM price evolution
DXCM
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $566.3 | $643.7 | $1194.9 | $623.2 |
| Short term investments | $2157.8 | $2596.6 | $2441.3 | $1943.8 |
| Net receivables | $973.9 | $785.7 | $750.6 | $636.8 |
| Inventory | $559.6 | $498.6 | $421.1 | $366 |
| Total current assets | $4425.9 | $4698.4 | $5002.9 | $3767.4 |
| Long term investments | ||||
| Property, plant & equipment | $1184.5 | $1152.3 | $1153.9 | $1153.5 |
| Goodwill & intangible assets | $159.7 | $169.8 | $180 | $189.3 |
| Total noncurrent assets | $1838.6 | $1897.8 | $1817.8 | $1748.5 |
| Total investments | $2157.8 | $2596.6 | $2441.3 | $1943.8 |
| Total assets | $6264.5 | $6596.2 | $6820.7 | $5515.9 |
| Current liabilities | ||||
| Accounts payable | $1345.5 | $1373.1 | $1156.5 | $965.2 |
| Deferred revenue | $18.4 | $9 | $9 | $9.6 |
| Short long term debt | $21.1 | $145.2 | $795.6 | $795.4 |
| Total current liabilities | $1556 | $1678.6 | $2069.7 | $1865 |
| Long term debt | $2514.3 | $2515.8 | $2517.5 | $1288.2 |
| Total noncurrent liabilities | $2639.9 | $2649.7 | $2650.6 | $1417.9 |
| Total debt | $2535.4 | $2661 | $3313.1 | $2083.6 |
| Total liabilities | $4195.9 | $4328.3 | $4720.3 | $3282.9 |
| Shareholders' equity | ||||
| Retained earnings | $1021.4 | $765.1 | $644.4 | $528.5 |
| Other shareholder equity | -$16.7 | -$35.6 | -$29.3 | -$6.5 |
| Total shareholder equity | $2068.6 | $2267.9 | $2100.4 | $2233 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $566.3 | $642.3 | $1052.6 | $817.6 |
| Short term investments | $2157.8 | $1813.9 | $1678.6 | $1890.1 |
| Net receivables | $973.9 | $713.3 | $514.3 | $428.5 |
| Inventory | $559.6 | $306.7 | $357.3 | $234.7 |
| Total current assets | $4425.9 | $3668.8 | $3684.4 | $3424.8 |
| Long term investments | ||||
| Property, plant & equipment | $1184.5 | $1135.6 | $889.9 | $608.6 |
| Goodwill & intangible assets | $159.7 | $199 | $68.5 | $19.3 |
| Total noncurrent assets | $1838.6 | $1722.9 | $1179.2 | $865.7 |
| Total investments | $2157.8 | $1813.9 | $1678.6 | $1890.1 |
| Total assets | $6264.5 | $5391.7 | $4863.6 | $4290.5 |
| Current liabilities | ||||
| Accounts payable | $1345.5 | $237.9 | $573 | $481.1 |
| Deferred revenue | $18.4 | $10.1 | $2.1 | $2.2 |
| Short long term debt | $21.1 | $793.1 | $20.5 | $16.5 |
| Total current liabilities | $1556 | $1839.3 | $720.8 | $614.1 |
| Long term debt | $2514.3 | $1257.3 | $1801.3 | $1769 |
| Total noncurrent liabilities | $2639.9 | $1420.6 | $1891.3 | $1849.9 |
| Total debt | $2535.4 | $2085.4 | $1821.8 | $1785.5 |
| Total liabilities | $4195.9 | $3259.9 | $2612.1 | $2464 |
| Shareholders' equity | ||||
| Retained earnings | $1021.4 | $479.9 | -$47.4 | -$202.1 |
| Other shareholder equity | -$16.7 | -$11.6 | $0.5 | $3.2 |
| Total shareholder equity | $2068.6 | $2131.8 | $2251.5 | $1826.5 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1034.5 | $975 | $871.3 | $741.5 |
| Cost of revenue | $377.9 | $351.7 | $324.9 | $278.9 |
| Gross Profit | $656.6 | $623.3 | $546.4 | $462.6 |
| Operating activities | ||||
| Research & development | $136.1 | $131.4 | $119.3 | $119 |
| Selling, general & administrative | $308.8 | $284.7 | $297.3 | $294.6 |
| Total operating expenses | $439.7 | $417.8 | $418.3 | $415.4 |
| Operating income | $216.9 | $205.5 | $128.1 | $47.2 |
| Income from continuing operations | ||||
| EBIT | $251.1 | $240.4 | $165.2 | $47.2 |
| Income tax expense | -$10.1 | $119.7 | $43.4 | $15.9 |
| Interest expense | $4.9 | $5.9 | -$17.3 | |
| Net income | ||||
| Net income | $256.3 | $120.7 | $115.9 | $48.6 |
| Income (for common shares) | $256.3 | $120.7 | $115.9 | $48.6 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3622.3 | $2909.8 | $2448.5 | $1926.7 |
| Cost of revenue | $1333.4 | $1026.7 | $768 | $646.6 |
| Gross Profit | $2288.9 | $1883.1 | $1680.5 | $1280.1 |
| Operating activities | ||||
| Research & development | $505.8 | $484.2 | $517.1 | $359.9 |
| Selling, general & administrative | $1185.4 | $1000.2 | $810.5 | $620.7 |
| Total operating expenses | $1691.2 | $1491.9 | $1414.7 | $980.6 |
| Operating income | $597.7 | $391.2 | $265.8 | $299.5 |
| Income from continuing operations | ||||
| EBIT | $730.7 | $391.4 | $275.9 | $309.7 |
| Income tax expense | $168.9 | $49.6 | $19.2 | -$268.6 |
| Interest expense | $20.3 | $0.6 | $102 | $84.7 |
| Net income | ||||
| Net income | $541.5 | $341.2 | $154.7 | $493.6 |
| Income (for common shares) | $541.5 | $341.2 | $154.7 | $493.6 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $256.3 | $120.7 | $115.9 | $48.6 |
| Operating activities | ||||
| Depreciation | $52.5 | $48.2 | $43.7 | $41.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $36.9 | $39 | $39.7 | $35.2 |
| Total cash flows from operations | $133.6 | $269.2 | $190.3 | $155.4 |
| Investing activities | ||||
| Capital expenditures | -$52.5 | -$50.4 | -$59 | -$74.7 |
| Investments | $466.5 | -$126.6 | -$480.9 | -$112 |
| Total cash flows from investing | $414.9 | -$179.5 | -$555.9 | -$186.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$500 | $14.3 | -$188.7 | $12.3 |
| Net borrowings | -$136.8 | -$650.5 | $1230.6 | |
| Total cash flows from financing | -$631.9 | -$637.4 | $939.5 | $11.2 |
| Effect of exchange rate | $6.1 | -$3.5 | -$2.2 | $1.1 |
| Change in cash and equivalents | -$77.3 | -$551.2 | $571.7 | -$19 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $541.5 | $341.2 | $154.7 | $493.6 |
| Operating activities | ||||
| Depreciation | $186 | $155.9 | $102 | $67.1 |
| Business acquisitions & disposals | -$3.9 | -$30.2 | ||
| Stock-based compensation | $150.8 | $126.5 | $113.4 | $119.4 |
| Total cash flows from operations | $748.5 | $669.5 | $442.5 | $475.6 |
| Investing activities | ||||
| Capital expenditures | -$236.6 | -$364.8 | -$389.2 | -$199 |
| Investments | -$253 | -$138.5 | $193.2 | -$807.7 |
| Total cash flows from investing | -$507.2 | -$521.5 | -$216.1 | -$1018 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$662.1 | -$535.2 | $20.3 | $15.3 |
| Net borrowings | $443.3 | $906.2 | ||
| Total cash flows from financing | -$318.6 | -$552.5 | $10.4 | $912.1 |
| Effect of exchange rate | $1.5 | -$5.8 | -$1.4 | $2.1 |
| Change in cash and equivalents | -$75.8 | -$410.3 | $235.4 | $371.8 |
News
Fundamentals
| Market cap | $51.76B |
|---|---|
| Enterprise value | $53.73B |
| Shares outstanding | 385.40M |
| Revenue | $3.62B |
|---|---|
| EBITDA | $889.90M |
| EBIT | $703.90M |
| Net Income | $541.50M |
| Revenue Q/Q | 26.90% |
| Revenue Y/Y | N/A |
| P/E ratio | 95.58 |
|---|---|
| EV/Sales | 14.83 |
| EV/EBITDA | 60.38 |
| EV/EBIT | 76.33 |
| P/S ratio | 14.29 |
| P/B ratio | 24.82 |
| Book/Share | 5.41 |
| Cash/Share | 1.47 |
| EPS | $1.41 |
|---|---|
| ROA | 8.60% |
| ROE | 24.98% |
| Debt/Equity | 2.03 |
|---|---|
| Net debt/EBITDA | 4.08 |
| Current ratio | 2.84 |
| Quick ratio | 2.48 |